Cancer Genetics said the deal is expected to provide it between $10 million and $12 million in revenues.
As part of the deal, expected to close on Oct. 9, Cancer Genetics will pay $14 million in cash and stock.
Oncimmune is repurchasing a CLIA-certified lab that it sold to Health Diagnostic Laboratory in October 2013.
True Health will pay $37.1 million to acquire substantially all the assets of Health Diagnostic Laboratory, which is currently in Chapter 11 reorganization.
Sengenics is rebranding the technology Immunome and expects it to expand the company's footprint in the proteomics space.
Illumina has not yet disclosed the price it paid for the Canadian laboratory information management systems software developer.
Roche is buying Lumora's heat elution technology, which enables nucleic acid isolation in minutes, as opposed to hours.
GeneWeave's rule-in antibiotic susceptibility testing works where PCR doesn't and offers Roche the possibility of reshaping the microbiology laboratory.
Roche will make a $190 million upfront payment to GeneWeave and could pay an additional $235 million in product-related milestones.
The Belgium-based testing firm believes acquiring the university laboratory will strengthen its position in specialty clinical diagnostic testing.
Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.
The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.
Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.
In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.